Furthermore, ABCF2 overexpression decreases apoptosis and increases cell viability following cisplatin treatment, indicating ABCF2 as a novel NRF2 target gene, playing a critical role in cisplatin resistance in ovarian cancer [84]. Here, ABCF2 is linked to ovarian carcinoma.